Ghent University Academic Bibliography

Your filters: cql: author="Dorward, Jienchi" or (type any "bookEditor issueEditor" and editor="Dorward, Jienchi")

Add to list
- Journal Article
- A1
- open access
Health outcomes 3 months and 6 months after molnupiravir treatment for COVID-19 for people at higher risk in the community (PANORAMIC) : a randomised controlled trial

Victoria Harris, Jane Holmes, Oghenekome Gbinigie-Thompson, Najib M Rahman, Duncan B Richards, Gail Hayward, Jienchi Dorward, David M Lowe, Joseph F Standing, Judith Breuer, et al.

(2025) LANCET INFECTIOUS DISEASES. 25(1). p.68-79
Add to list
- Journal Article
- A1
- open access
Favipiravir for COVID-19 in adults in the community in PRINCIPLE, an open-label, randomised, controlled, adaptive platform trial of short- and longer-term outcomes

FD Richard Hobbs, Oghenekome A. Gbinigie-Thompson, Milensu Shanyinde, Ly-Mee Yu, Victoria Harris, Jienchi Dorward, Gail Hayward, Benjamin R. Saville, Nicholas S. Berry, Philip H. Evans, et al.

(2024) JOURNAL OF INFECTION. 89(4).
Add to list
- Journal Article
- A1
- open access
Cost-utility analysis of molnupiravir for high-risk, community-based adults with COVID-19 : an economic evaluation of the PANORAMIC trial

May Ee Png, Victoria Harris, Jenna Grabey, Nigel D Hart, Bhautesh D Jani, Daniel Butler, Andrew Carson-Stevens, Maria Coates, Lucy Cureton, Melissa Dobson, et al.

(2024) BRITISH JOURNAL OF GENERAL PRACTICE. 74(745). p.E570-E579
Add to list
- Journal Article
- A1
- open access
Randomized controlled trial of molnupiravir SARS-CoV-2 viral and antibody response in at-risk adult outpatients

Joseph F. Standing, Laura Buggiotti, Jose Afonso Guerra-Assuncao, Maximillian Woodall, Samuel Ellis, Akosua A. Agyeman, Charles Miller, Mercy Okechukwu, Emily Kirkpatrick, Amy I. Jacobs, et al.

(2024) NATURE COMMUNICATIONS. 15(1).

Academic Bibliography

Health outcomes 3 months and 6 months after molnupiravir treatment for COVID-19 for people at higher risk in the community (PANORAMIC) : a randomised controlled trial

Favipiravir for COVID-19 in adults in the community in PRINCIPLE, an open-label, randomised, controlled, adaptive platform trial of short- and longer-term outcomes

Cost-utility analysis of molnupiravir for high-risk, community-based adults with COVID-19 : an economic evaluation of the PANORAMIC trial

Randomized controlled trial of molnupiravir SARS-CoV-2 viral and antibody response in at-risk adult outpatients

Contents

Support

Contact